Polyvidone (povidone) iodine


General information

Polyvidone (polyvinylpyrrolidone, povidone) is a variable-weight polymer of the monomer N-vinylpyrrolidinone. When it enters the body, it causes histologically characteristic reactions in tissues with which it comes into contact [ , ].

Polyvidone co-polymers are used in cosmetics as antimicrobials, antistatics, binding compounds, stabilizers of emulsions, and film-forming, viscosity-controlling, hair-fixing, skin-conditioning, and skin-protective agents. Polyvidone is used as a component of hair sprays and as a retardant for subcutaneous injections. It was formerly used as a plasma expander [ ] and has been inappropriately used for intravenous injection as a “blood tonic”, especially in Asian societies. Some products intended for parenteral administration contain polyvidone as an excipient. Polyvidone is widely used as a suspending and coating agent in tablets, for its film-forming properties in eye drops, and as a carrier molecule for iodine in disinfectants. About 20% of all tablets on the market contain polyvidone. It is also used in the cosmetics industry as a dispersing agent and as a lubricant in ointments.

Absorption from different sites of application

Povidone iodine is formulated as a 10% applicator solution, a 2% cleansing solution, and in many topical formulations, for example aerosol sprays, aerosol foams, vaginal gels, ointments, and mouthwashes. Because it contains very little free iodine (less than 1 ppm in a 10% solution), its antibacterial effectiveness is only moderate compared with that of a pure solution of iodine. The extent of systemic absorption of povidone iodine depends on the localization and the conditions of its use (area, skin surface, mucous membranes, wounds, body cavities).

Healthy skin

Repeated surgical skin antisepsis and hand washing did not increase serum iodine concentrations, but produced a small increase in iodine content in the 24-hour urine [ ].

Burns

The use of povidone iodine for the treatment of burns, for peritoneal lavage in the treatment of purulent peritonitis, or as a rinsing solution for body cavities can increase serum iodine concentrations associated with increased urinary excretion of iodine. In people with burns, the extent of iodine absorption depends on the extent of the burned body surface. It is not uncommon for serum iodine concentrations to rise to more than 1000 μg/ml. If renal function is intact, iodine elimination in the urine can be adequate. The serum iodine concentration returns to normal about 1 week after the last application.

The penetration of povidone iodine has been studied in vivo in rabbits [ ]. The penetration from third-degree burns on the back was measured autoradiographically in tissues, blood, urine, and bandages. The results showed that about 20% of iodine is absorbed through fresh necrosis, whereas only 5% is absorbed through a clean wound or 24-hour-old necrosis. The passage through burn necrosis was faster than through vital tissue.

In repeated topical use on burns, the extent of absorption seems to decrease with the treatment time.

Wounds

Povidone iodine inhibits leukocyte migration and fibroblast aggregation in wounds. The effect on the wound healing process has been studied in 294 children undergoing surgery, 283 of whom had undergone appendectomy [ ]. In a first series using 5% povidone iodine aerosol for preoperative disinfection, the postoperative wound infection rate was 19% in the test group and only 8% in the controls. When a 1% povidone iodine solution was used, only 2.6% of the patients were infected (control group 8.5%). Using a drain with a cellulose viscose sponge, 5% povidone iodine by aerosol inhibited leukocyte migration, but no cell aggregates or fibroblasts were detected. A 5% solution allowed better cellular movement and attachment to the framework, polymorphonuclear leukocytes predominating. The excipients in the aerosol formula must be more toxic to the cell than those in the solution. If a 1% povidone iodine solution was absorbed by the sponge, the aggregation phenomenon was only slightly averted and cell morphology was similar to that of the saline control.

Povidone iodine reduced the number of wound infections only in patients with appendicitis in whom neither peritonitis nor a periappendicular abscess had yet developed [ ].

Mucous membranes

The effect of a povidone iodine mouthwash on thyroid function has been studied in 16 medically healthy volunteers [ ]. After they had used the mouthwash four times daily for a period of 14 days, all thyroid tests were significantly changed, but there was no suppression of thyroid function. However, this was not to be expected, considering the short test period.

Body cavities

When povidone iodine is used as a rinsing solution in body cavities, absorption of the whole macromolecular complex is possible. The complex has a molecular weight of about 60 000 and cannot be eliminated by the kidneys or metabolically. It is filtered by the reticuloendothelial system [ ].

Although povidone iodine is no longer used in dialysates, a povidone iodine-containing cap is used to seal the Tenckhoff catheter during the day. Iodine-induced hypothyroidism occurred in a 3-year-old boy and an 18-month-old girl, in both cases due to the sealing cap [ ]. The povidone iodine inside the cap diffused into the catheter and flushed into the peritoneal cavity at the next dialysis session.

Intravaginal administration

Systemic iodine absorption can occur after intravaginal administration of povidone iodine [ ]. There were increases in serum iodine, protein-bound iodine, and inorganic iodine, but not serum thyroxine, after a 2-minute vaginal administration of povidone iodine in non-pregnant women [ ].

Guidelines for the safe use of povidone iodine complexes

In 1985, a working group of the Federal German Medical Association issued a number of recommendations for the safe use of povidone iodine complexes [ ]. They remain valid and can be summarized as follows:

  • 1.

    The application of povidone iodine formulations cannot be recommended for surgical hand disinfection, since active iodine-free formulations are available.

  • 2.

    The activity of povidone iodine in preoperative skin disinfection in adults is well proven.

  • 3.

    Povidone iodine is appropriate for skin disinfection before an incision, a puncture, with use of intravenous or arterial catheters, and for the prophylaxis of iatrogenic Clostridia infections.

  • 4.

    In the case of superficial wounds, povidone iodine can be applied occasionally or repeatedly in spite of increased iodine absorption through the broken skin surfaces.

  • 5.

    Lavage of wound and body cavities with povidone iodine or its instillation is not indicated because of increased iodine absorption.

  • 6.

    Routine body washing of patients in intensive care units is not cost-beneficial.

  • 7.

    Vaginal administration of povidone iodine is not recommended.

  • 8.

    Povidone iodine is contraindicated in premature babies and neonates; this also applies to prophylactic disinfection of the umbilical stump.

  • 9.

    The clinical usefulness of povidone iodine in the treatment of burns is well proven.

  • 10.

    Local mouth antiseptics serve no therapeutic purpose; this is also true for povidone iodine.

Drug studies

Observational studies

In a meta-analysis of observational studies of povidone iodine for chemical pleurodesis, the only significant complication was chest pain of varying degree [ ]. Systemic hypotension was reported in three patients in only one study. There were no deaths related to chemical pleurodesis. Overall, the review supported the safety and efficacy of povidone iodine as an agent for chemical pleurodesis.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here